Digestive System Diseases  >>  epirubicin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00215514: Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma

Completed
1
25
US
Epirubicin, Cisplatin, 5-Fluorouracil (5-FU), Radiation
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital
Stomach Cancer, Gastric Cancer, Gastro-esophageal Junction Cancer
11/03
07/14
EMD 72000-024, NCT00113581: Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer

Completed
1
26
Europe
EMD 72000 (matuzumab) + ECX
Merck KGaA, Darmstadt, Germany
Esophageal Cancer, Gastric Cancer
05/06
01/07
NCT00486356: Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Completed
1
46
US
capecitabine, Xeloda, carboplatin, Paraplatin, epirubicin hydrochloride, Ellence, microarray analysis, polymorphism analysis, pharmacological study
University of Nebraska, National Cancer Institute (NCI)
Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Liver Cancer, Unspecified Adult Solid Tumor, Protocol Specific
01/10
01/10
VEOX, NCT01386346: Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Completed
1
12
US
Azacitidine, Vidaza®, 5-Azacitidine, Oxaliplatin, Eloxatin, Epirubicin, Ellence, Capecitabine, Xeolda
Weill Medical College of Cornell University, Celgene Corporation
Esophageal Cancer, Malignant Neoplasm of Cardio-esophageal Junction of Stomach
08/14
09/18

Download Options